| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |